Advance Sentry Corporation

Advance Sentry Corporation (ASC) was established in 1999 by Canadian prominent physicians and inventors in Canada focused on the early detection of cancers. Early detection is the key for preventive medicine. The company firmly believes in early detection and early treatment will be the key to change the course of the disease. NP Screen™ technology is first commercially available test with 99% accuracy and potential detects the earliest form of Nasopharyngeal Carcinoma. The company continue to develop innovative screening technologies and conduct clinical studies in order to develop even more sensitive and quantifiable standards for diagnosis of disease.

• Employees 1
• Founded 1999